TBPH - Theravance Biopharma, Inc.
IEX Last Trade
9.83
-0.045 -0.458%
Share volume: 2,671
Last Updated: Thu 26 Dec 2024 08:29:41 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$9.88
-0.05
-0.46%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-09 | 2023-03-01 | 2023-05-10 | 2023-08-09 | 2023-11-09 | 2024-03-01 | 2024-05-15 | |
| Total revenue | 11.050 M | 12.451 M | 14.649 M | 10.417 M | 13.749 M | 15.693 M | 17.565 M | 14.503 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 11.050 M | 12.451 M | 14.649 M | 10.417 M | 13.749 M | 15.693 M | 17.565 M | 14.503 M | |
| 12.68% | 17.65% | -28.89% | 31.99% | 14.14% | 11.93% | -17.43% | |||
| Operating expenses | 32.557 M | 26.144 M | 29.390 M | 33.755 M | 28.703 M | 24.453 M | 23.805 M | 25.710 M | |
| Selling general and admin | 16.986 M | 16.277 M | 14.689 M | 19.183 M | 19.278 M | 16.142 M | 15.492 M | 16.742 M | |
| Research and development | 15.571 M | 9.867 M | 14.701 M | 14.572 M | 9.425 M | 8.311 M | 8.313 M | 8.968 M | |
| Total expenses | 32.557 M | 26.144 M | 29.390 M | 33.755 M | 28.703 M | 24.453 M | 23.805 M | 25.710 M | |
| -19.70% | 12.42% | 14.85% | -14.97% | -14.81% | -2.65% | 8.00% | |||
| Operating income | -21.507 M | -13.693 M | -14.741 M | -23.338 M | -14.954 M | -8.760 M | -6.240 M | -11.207 M | |
| Ebit | 6.620 M | -13.693 M | -67.978 M | -23.338 M | -14.954 M | -8.760 M | -6.240 M | -11.207 M | |
| Pretax income | -8.196 M | -16.023 M | -43.174 M | -22.483 M | -14.187 M | -7.583 M | -5.016 M | -10.402 M | |
| 95.50% | 169.45% | -47.92% | -36.90% | -46.55% | -33.85% | 107.38% | |||
| Income tax | -5.000 K | 0.000 | -510.000 K | -395.000 K | 1.458 M | 1.367 M | 3.494 M | 1.262 M | |
| Net income basic | -8.191 M | 916.631 M | -10.362 M | -22.088 M | -15.645 M | -8.950 M | -8.510 M | -11.664 M | |
| 11,290.71% | -101.13% | -113.16% | 29.17% | 42.79% | 4.92% | -37.06% | |||
| Net income | -8.191 M | 916.631 M | -10.362 M | -22.088 M | -15.645 M | -8.950 M | -8.510 M | -11.664 M | |
| 11,290.71% | -101.13% | -113.16% | 29.17% | 42.79% | 4.92% | -37.06% |